Number | Variable | OR (95% CI) | P |
---|---|---|---|
1 | Age | 1.10 (1.01–1.20) | 0.025 |
2 | Bedridden time after hip fracture | 1–12 month, 1.37 (0.21–8.80) | 0.003 |
Reference, < 1 month | > 12 month, 8.60 (2.18–33.9) | ||
3 | Indwelling nasal feeding | 9.16 (2.70, 31.1) | < 0.001 |
4 | Number of hospitalizations in the past year | 1.47 (1.09–1.98) | 0.011 |
5 | Days of hospitalization | 1.04 (1.01–1.08) | 0.027 |
6 | Serum albumin level | 0.79 (0.68–0.90) | < 0.001 |
7 | Infection with drug-resistant fungus | 7.55 (2.19, 26.1) | 0.001 |
8 | Infection with drug-resistant bacteria | 10.7 (3.22–35.4) | < 0.001 |
9 | Third-generation cephalosporins (without enzyme inhibitors) | 3.17 (1.09–9.24) | 0.034 |
10 | Antibiotics need to be upgraded | 7.68 (2.41–24.4) | < 0.001 |
11 | Numbers of antibiotics upgrade M | 2.27 (1.43–3.61) | < 0.001 |
12 | Use of antifungal drugs | 5.50 (1.81–16.7) | 0.003 |
13 | Use of glucocorticoids during antibiotic therapy | Oral, 5.06 (0.41–62.1) | < 0.001 |
Reference, not used | Intravenous, 81 (8.96–732) | ||
14 | Use of glucocorticoids | 30.4 (6.81–135) | < 0.001 |
15 | Parenteral nutrition support | 8.43 (2.70–26.4) | < 0.001 |
16 | Tracheal intubation or tracheotomy | 4.86 (1.15–20.5) | 0.031 |